EcoDrugPlus

Il2 Inducible T Cell Kinase

Ensembl ID : ENSAPOG00000010426
Gene Symbol: ITK
3 Cross references
208 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSAPOG00000002744
Gene Symbol: JAK1
3 Cross references
214 Possible Orthologues:

Kras Proto-Oncogene, Gtpase

Ensembl ID : ENSAPOG00000014783
Gene Symbol: KRAS
3 Cross references
208 Possible Orthologues:

Malt1 Paracaspase

Ensembl ID : ENSAPOG00000000151
Gene Symbol: MALT1
3 Cross references
198 Possible Orthologues:

Map Kinase-Activated Protein Kinase 2-Like

Ensembl ID : ENSAPOG00000003470
Gene Symbol: LOC110956438
3 Cross references
174 Possible Orthologues:

Mapk Activated Protein Kinase 2

Ensembl ID : ENSAPOG00000010946
Gene Symbol: MAPKAPK2
4 Cross references
186 Possible Orthologues:

Mapk Activated Protein Kinase 5

Ensembl ID : ENSAPOG00000014646
Gene Symbol: MAPKAPK5
3 Cross references
179 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 2

Ensembl ID : ENSAPOG00000012248
Gene Symbol: MKNK2
3 Cross references
208 Possible Orthologues:

Mdm2 Proto-Oncogene

Ensembl ID : ENSAPOG00000022768
Gene Symbol: MDM2
3 Cross references
281 Possible Orthologues:

Met Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSAPOG00000019826
Gene Symbol: MET
3 Cross references
204 Possible Orthologues:

Mtor Associated Protein, Lst8 Homolog

Ensembl ID : ENSAPOG00000000988
Gene Symbol: MLST8
3 Cross references
195 Possible Orthologues:

Nadph Oxidase 4

Ensembl ID : ENSAPOG00000007989
Gene Symbol: NOX4
4 Cross references
150 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).